Jeffrey B. Mirviss
Equibles does not estimate personal net worth.
About Jeffrey B. Mirviss
Boston Scientific Corp reported in an 8-K filed September 4, 2025 that Jeffrey B. Mirviss retired as Executive Vice President and President, Peripheral Interventions, effective December 1, 2025. The proxy statement of Boston Scientific Corp reports total compensation of $4,159,959 for Jeffrey B. Mirviss in fiscal 2025, including a base salary of $702,042. Disclosed compensation is on record for 6 fiscal years.
“On August 29, 2025, Jeffrey B. Mirviss informed Boston Scientific Corporation (the "Company") that he has decided to retire from his role as Executive Vice President and President, Peripheral Interventions effective as of December 1, 2025.”
Affiliation history
-
Boston Scientific Corp (BSX)
Proxy statement
Start not stated–2025-12-01
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Boston Scientific Corp (BSX) | Executive Vice President and President, Peripheral Interventions | $702,042 | $4,159,959 |
| 2024 | Boston Scientific Corp (BSX) | Executive Vice President and President, Peripheral Interventions | $680,411 | $4,027,076 |
| 2023 | Boston Scientific Corp (BSX) | Executive Vice President and President, Peripheral Interventions | $652,646 | $3,782,995 |
| 2022 | Boston Scientific Corp (BSX) | Executive Vice President and President, Peripheral Interventions | $631,986 | $3,562,244 |
| 2021 | Boston Scientific Corp (BSX) | Executive Vice President and President, Peripheral Interventions | $598,249 | $3,456,145 |
| 2020 | Boston Scientific Corp (BSX) | Executive Vice President and President, Peripheral Interventions | $495,001 | $2,956,196 |